Sana Amoozegar is a Research Fellow at the Department of Neurology within the University of Minnesota Medical School . Her work bridges Neuroscience , Biomedical Engineering , and Neurotechnology through deep brain stimulation (DBS) research. Her research focuses on: Therapeutic applications of DBS in Parkinsonian models Neural network modulation in subthalamic pathways Development of closed-loop neuromodulation systems Neuroimaging techniques for seizure localization Recent publications demonstrate expertise in Neuroengineering , including DBS optimization (2025), subthalamic coherence analysis (2024), and LFP-based stimulation systems (2022). She also contributes to Cardiac Risk Prediction (2018) and Neurological Signal Processing (2013).
William Horton is an Assistant Teaching Professor at the Biobehavioral Health Department within Penn State University's College of Health and Human Development . His research focuses on the intersection of circadian rhythms and substance abuse, particularly nicotine addiction, examining how molecular and genetic changes influence behavior and vice versa. Education Ph.D. in Integrative Physiology and Neuroscience from University of Colorado - Boulder B.S. in Zoology from Michigan State University Research Interests encompass: Molecular mechanisms linking circadian rhythms and addiction Genetic influences on drug-seeking behavior Neuroimaging of substance exposure effects Environmental factors (light, sleep) in maternal and child health Stress interactions with opioid and nicotine addiction Translational preclinical models of addiction and aging Selected Publications demonstrate expertise in neurogenetics, sleep disorders, and addiction science, with recent work on miRNA regulation in stress models (2024), opioid neuroimaging (2023), and cross-species transcriptomic studies (2019).
Dr Ian E Smith is a Consultant Physician and Medical Director at Royal Papworth Hospital, UK, with a focus on research direction and clinical innovation in respiratory and sleep medicine. He is also an Affiliated Associate Professor at the University of Cambridge. BA (Hons) Medical Sciences MA (1988) MBBS (1987) MRCP (London, 1990) MD (Cambridge University, 1997) FRCP (London, 2000) His research spans respiratory support and sleep disorders , including pioneering work on home ventilation, COPD exacerbations, and motor neurone disease (MND) care. He co-authored NICE guidelines for MND and led the establishment of the Papworth Clinical Trials Unit. Recent publications highlight his expertise in sleep apnoea , ventilation strategies , and interdisciplinary topics like neuro-immune interactions and vasodilation mechanisms . His work includes systematic reviews, clinical trials, and translational studies. ARTP award for services to Respiratory Medicine (2016) Dr Smith has held leadership roles in the UK Association of Respiratory Technicians and Physiologists sleep section and contributed to national guidelines on sleep apnoea and driving. He founded the UK's first European-accredited Respiratory Support and Sleep Centre (RSSC) and developed a regional MND care network.
Ranjan Dash is a Professor and Co-Director of Graduate Studies in the Joint Department of Biomedical Engineering at Marquette University and Medical College of Wisconsin. He also serves as Professor in the MCW Department of Physiology and Director of the Computational Systems Biology Laboratory (CSBL). His academic career spans prestigious institutions including Case Western Reserve University, University of Washington, and Texas A&M University where he completed postdoctoral training in computational systems biology and biofluid dynamics. Ph.D. in Computational Biofluid Dynamics, Indian Institute of Technology, Delhi, India (1998) M.Sc. in Applied Mathematics, Utkal University, Bhubaneswar, Orissa, India (1991) Dash's research focuses on computational systems biology and bioengineering with emphasis on mitochondrial, cellular and cardiovascular physiology. His work integrates mathematical modeling with experimental approaches to study cellular/mitochondrial metabolism and redox biology. Specific research areas include pulmonary and systemic microcirculatory gas exchange, physiologically-based pharmacokinetic modeling, blood-tissue solute transport, large-scale biochemical networks, cellular calcium and reactive oxygen species signaling, cardiac electrophysiology, and renal metabolism in salt-sensitive hypertension. His recent publications demonstrate a strong emphasis on computational modeling of physiological systems, particularly in the areas of mitochondrial bioenergetics, renal function in hypertension, CAR T-cell therapy modeling, and ischemia-reperfusion injury assessment. His work bridges computational approaches with experimental validation across multiple organ systems. Dean's Choice Outstanding Graduate School Educator Award (2019-2020, 2016-2017) Award of Tenure for scholarly achievements (2018) Outstanding Faculty Service Award (2015) Founding Faculty, Virtual Physiological Rat Center (2011) Marquis Who's Who in Science and Engineering (2011-2012) Dash has secured significant research funding as Principal or Co-Principal Investigator from major organizations including NIH, NSF, and Advancing a Healthier Wisconsin Endowment. His current projects focus on high salt effects on renal metabolism, computational modeling of CAR T-cell therapy, and advanced ion channel modeling. As Co-Director of Graduate Studies, he plays a key role in shaping the next generation of biomedical engineers while leading the Computational Systems Biology Laboratory. The Computational Systems Biology Laboratory under Dash's direction serves as a hub for interdisciplinary research, bringing together engineers, physiologists, and computational scientists to tackle complex problems in systems physiology and disease mechanisms.
Professor Andrew Boyle is a distinguished cardiologist and researcher at the University of Newcastle's School of Medicine and Public Health, where he serves as Professor of Cardiovascular Medicine and Head of Discipline. His career spans prestigious institutions including Monash University, St Vincent's Hospital Melbourne, Johns Hopkins University, and the University of California San Francisco, where he was Associate Professor of Medicine. Currently based at the Hunter Medical Research Institute (HMRI) and John Hunter Hospital, he leads significant cardiovascular research initiatives while providing clinical care. Boyle obtained his medical degree from Monash University, completed cardiology advanced training at St Vincent's Hospital Melbourne, earned a PhD in Medicine from the University of Melbourne, and completed fellowship training at Johns Hopkins University. His academic journey includes seven years as faculty at the University of California San Francisco, where his NIH-funded laboratory focused on aging and left ventricular remodeling. Professor Boyle's research focuses on left ventricular remodeling following heart attacks and with aging, with particular emphasis on molecular and cellular mechanisms of fibrosis, cardiac stem cell function, and cardiac regeneration. His laboratory at HMRI employs multiple preclinical models to investigate apoptosis, stem cell behavior, and fibrosis pathways. His translational research bridges laboratory findings with clinical applications, while his clinical research examines systems of care and novel therapies for optimizing cardiovascular outcomes after heart attacks and transcatheter aortic valve implantation. An analysis of his recent publications reveals a strong focus on clinical cardiology research, particularly examining STEMI care disparities between rural and metropolitan regions, innovative interventional techniques, biomarkers for cardiovascular risk prediction, and sex-based differences in heart disease. His work increasingly addresses healthcare system challenges, including rural access to cardiac care and patient-centered approaches to cardiac procedures. Fellow - Society for Cardiac Angiography and Intervention Fellow - American Heart Association Fellow - American College of Cardiology Professor Boyle actively supervises research higher degree students in his laboratory and teaches medical and biomedical science students at all levels. He serves as Clinical Dean of the Hunter Clinical School for the Joint Medical Program of the Universities of Newcastle and New England. His administrative leadership includes roles as Co-Director of the Heart and Stroke Research Program at HMRI, Chair of the Clinical Trials Subcommittee of the Hunter New England HREC, and Chair of the Executive Committee of the NSW Cardiovascular Research Network. His extensive collaborations span Oxford University, multiple Australian universities, the Medical University of Graz, and institutions in China. His research laboratory at HMRI brings together basic scientists, translational researchers, and clinicians to investigate cardiac remodeling mechanisms. The team maintains ongoing collaborations with international institutions and participates in the Regional Rural and Remote Clinical Trial Enabling Program, focusing on improving cardiovascular care delivery in underserved regions.
Don Adjeroh is a Professor and Associate Chair in the Lane Department of Computer Science and Electrical Engineering at West Virginia University (WVU). He serves as Graduate Coordinator for CS programs and has led multiple NSF-sponsored projects including Bridges in Digital Health and Multi-Scale Integrative Approach to Digital Health . His research focuses span Machine Learning , Bioinformatics , Computational Biology , and Data Compression . NSF CAREER Award recipient Collaborated with institutions like University of Central Florida and University of Canterbury Led workshops on Plant Image Analysis and Long Non-Coding RNA research His academic contributions include co-authoring the book The Burrows Wheeler Transform: Data Compression, Suffix Arrays, and Pattern Matching (Springer, 2008) and developing software tools like BSMP and PSA for data compression and protein family modeling. He teaches graduate-level courses in String Algorithms and Information Theory , with former projects involving undergraduate and graduate students in DNA microarray image processing and 3D video compression research. Key Scientific Awards : NSF CAREER Award NASA-WV Space Consortium funding WV-EPSCOR grants NSF-CITeR support DOD-ONR/DHS/DOJ/NIJ/NHPRC sponsorships
Dr. Jason Hong is a board-certified pulmonary and critical care physician at University of California, Los Angeles (UCLA), providing care in Westwood and Santa Monica hospitals. As a Clinical Assistant Professor at the David Geffen School of Medicine, he focuses on pulmonary vascular diseases including pulmonary arterial hypertension (PAH) , combining experimental research with computational approaches to uncover molecular mechanisms. Undergraduate: University of California, Berkeley MPH: University of California, Berkeley Medical Degree: Loma Linda University PhD: Molecular, Cellular, and Integrative Physiology at UCLA Residency: Internal Medicine at Columbia University Fellowship: Pulmonary and Critical Care at UCLA Hong's research spans translational studies of PAH pathobiology, including single-cell transcriptomics , multi-omics analysis , and molecular imaging . His work identifies novel therapeutic targets like Asporin , TM4SF1 , and LOXL2 , while exploring sex differences and neuroinflammatory pathways in pulmonary hypertension. Recent publications highlight trends in single-cell sequencing , digital spatial profiling , and RNA-binding protein functions . His team integrates preclinical models with clinical sample analysis to bridge molecular insights to patient therapies, particularly in right ventricular failure and pulmonary fibrosis comorbidities. Hong collaborates with UCLA's multidisciplinary researchers in cardiovascular physiology and pulmonary medicine, though no specific lab or grant details are mentioned in the provided text. His work appears in journals including Circulation , Am J Respir Cell Mol Biol , and Hypertension .
Jan Lammerding is a Professor at Cornell University's Meinig School of Biomedical Engineering and the Weill Institute for Cell and Molecular Biology. His research focuses on nuclear mechanobiology, investigating how mechanical forces affect nuclear structure and function in cancer metastasis and muscular dystrophies. He has developed microfluidic platforms to study nuclear deformation and holds fellowships from BMES, AIMBE, and ASCB. Education: Diplom Ingenieur (RWTH Aachen), B.E. (Dartmouth), Ph.D. (MIT) Leadership: Director of Graduate Studies (2011-2024), Associate Director of Meinig School (2024-) Research spans nuclear envelope rupture in cancer cells, mechanotransduction pathways, and Ledercq Foundation-funded projects on laminopathies. His lab has produced 15+ articles (2023-2025) covering topics like microtubule-induced nuclear damage , 3D hydrogel migration , and mechanical stress epigenetic effects . Awards include Keith Porter Medal , NSF CAREER , and Cornell Teaching Excellence honors.
Jason D. Adler is a Clinical Associate Professor in the Department of Emergency Medicine. His academic contributions focus on clinical challenges in emergency care, critical care, and trauma management. Dr. Adler's research interests span Emergency Medicine , Critical Care , Trauma , and Medical Imaging , with a strong emphasis on clinical deterioration in infectious disease contexts, weapon-related injuries, and cardiovascular emergencies. His recent scholarly work trends include studies on Emergency Care Imaging , Trauma Assessment , and Public Health Responses to Pandemics . These publications reflect his engagement with high-impact clinical scenarios requiring rapid diagnostic and intervention strategies.
Professor Cormac Taylor is a Full Professor at the School of Medicine, University College Dublin, where he leads a research group at the UCD Conway Institute. His research focuses on hypoxia-mediated transcriptional regulation in epithelial cells, with applications in chronic inflammatory diseases. He holds a PhD in Pharmacology from University College Dublin (1996) and completed postdoctoral research at Harvard Medical School. His research investigates: Hypoxia-inducible factor (HIF) signaling pathways Metabolic reprogramming during oxygen stress Epithelial cell responses to inflammatory stimuli Therapeutic targeting of hypoxia pathways in disease Host-microbe interactions in gastrointestinal inflammation Research outputs demonstrate consistent focus on hypoxia-mediated metabolic adaptation, with recent work exploring HIF's role in cancer, diabetes, and infection biology. Articles show advanced techniques in metabolomics, transcriptomics, and molecular pathway analysis. Awards & Honors: Elected to Royal Irish Academy (2013) - Highest Irish academic honor Nature Award for Mentoring in Science (2014) Takeda Distinguished Researcher Award (2016) - First non-US recipient Research Leadership: Maintained continuous funding from Science Foundation Ireland since 2002 with additional grants from Wellcome Trust and NIH. Successfully supervised 16 PhD students. Serves as Managing Editor of Frontiers in Biosciences and Editorial Board Member for American Journal of Physiology. Laboratory: Leads hypoxia research group at UCD Conway Institute investigating therapeutic targeting of hypoxia pathways in chronic inflammation and cancer.
Marilia Cascalho is a Professor and Vice Chair for Research at the Department of Pathology, Case Western Reserve University School of Medicine. She also serves as a Member of the Immune Oncology Program at the Case Comprehensive Cancer Center. Her academic journey includes MD and PhD degrees from the University of Lisbon and UCSF, respectively, followed by postdoctoral training at the Hagedorn Research Institute and UCSF. Key Appointments : Vice Chair for Research (2024), Richard J. Fasenmyer Professor (2024) Prior Institutions : Mayo Clinic (1999-2008), University of Michigan (2008-2024) Research Interests focus on Immunobiology of organ transplantation Genetic susceptibility in immune-mediated diseases Development of mutable vaccines against viral evolution C3d-based immunotherapies for cancer TACI/TNFRSF13B polymorphisms in immunity Article Trends reveal contributions to transplantation science, B cell immunology, and cancer immunotherapy. Her work spans antibody-mediated immunity , adaptive immune responses , and somatic hypermutation mechanisms , with recent emphasis on piRNA biomarkers in transplant monitoring and metabolic reprogramming for graft survival . Scientific Awards include: Science Magazine Prize for Young Investigators (1999) NIH Grant Support (multiple awards) Gates Foundation Grant US-Israel Bi-National Science Foundation NIH Study Section Memberships Patents and Innovation highlight her inventions in Soluble C3d immunotherapies Mutable vaccine technology B cell repertoire analysis methods T cell diversity modulation Laboratory Focus integrates immunology, genetics, and bioengineering to develop therapies for transplant rejection, autoimmune diseases, and incurable cancers like multiple myeloma.
Kendall Hunter, PhD serves as Associate Professor in the Department of Bioengineering at the University of Colorado School of Medicine, Anschutz Medical Campus. Affiliated with both the University of Colorado Denver and Children's Hospital Colorado, Hunter maintains clinical practice at the Aurora campus (13123 East 16th Ave). The academic appointment resides within the College of Engineering, Design and Computing's Bioengineering department, which operates jointly across the Anschutz Medical Campus and Denver campus. Hunter's research focuses at the intersection of cardiovascular physiology, neural engineering, and medical imaging technologies. Primary investigation areas include right ventricular-pulmonary arterial coupling, Fontan circulation hemodynamics, and advanced cardiac imaging techniques like 4D flow MRI. The work frequently addresses clinical challenges in pulmonary hypertension, congenital heart disease, and metabolic disorders affecting cardiovascular function. Recent publications demonstrate strong emphasis on developing computational models and novel imaging algorithms for cardiovascular assessment. Analysis of the 15 most recent publications reveals consistent focus on ventricular-vascular interactions, particularly in challenging clinical populations including pediatric patients with pulmonary hypertension, Fontan circulation, and metabolic disorders. The research methodology heavily utilizes advanced imaging modalities (4D flow MRI, echocardiography), hemodynamic monitoring, and computational analysis techniques including principal component analysis for complex clinical data. Principal investigator for neural engineering research within the Bioengineering department Active collaborator with Children's Hospital Colorado clinical teams Involved in graduate education through the Neural Engineering certificate program Hunter's laboratory work connects closely with the Center for Bioengineering at Bioscience 2 (12705 East Montview Boulevard), leveraging the unique co-location of engineering and medical facilities at the Anschutz campus. Current research directions include developing ultrasound algorithms for critical care applications and investigating perivascular adipose tissue interactions in metabolic disease models.
Glenda Comai is a Permanent Researcher (CRCN CNRS) at the Department of Developmental and Stem Cell Biology, CNRS UMR 3738, Institut Pasteur, Paris, where she has worked since 2016 in Prof. Shahragim Tajbakhsh's laboratory. She serves on the Advisory Board of the French Society of Developmental Biology (SFBD) since 2019 and recently obtained her HDR (Habilitation à diriger des Recherches) from Université Paris Saclay in 2024. Her research focuses on understanding the mechanisms underlying tissue patterning during development, with special emphasis on craniofacial muscles. Using 3D-imaging, mouse genetics, and single cell/single nuclear omics approaches, she investigates how heterogeneity at the level of stem cells and myofibers is established and how this impacts muscular genetic disorders. Her work reveals significant differences between extraocular muscle stem cells and those from limb muscles, particularly in their regenerative capacity and molecular signatures. Analysis of her recent publications shows a strong trend toward understanding the transcriptional and epigenetic regulation of muscle stem cell identity, particularly how anatomical location influences stem cell behavior. Her research spans developmental biology, stem cell biology, and muscle physiology, with particular emphasis on craniofacial development and muscle regeneration mechanisms. AFM PRC Grant (2024-2026) ANR JCJC Grant (2021-2024) AFM Trampolin Grant (2020-2021) As Principal Investigator, Dr. Comai leads two major research projects: AFM-Trampolin: Cellular and genetic basis for robustness of cranial myogenic populations (ENCRYPT) and ANR-JCJC: Mechanisms defining functional heterogeneity of anatomically distinct myogenic populations (MUSE). Her laboratory employs advanced techniques including bioimage analysis, confocal microscopy, stem cell culture, and various molecular biology methods to investigate muscle development and regeneration.
Christopher Goodchild, Ph.D., serves as Associate Professor in the Biology Department at the University of Central Oklahoma, where he joined in 2020 following a postdoctoral position at Virginia Tech. His research integrates molecular physiology with whole-organism ecology to assess environmental contaminant impacts. His educational background: Ph.D. in Integrative Biology, Oklahoma State University (2019) M.S. in Marine Sciences, University of New England (2014) B.S. in Zoology and Biomedical Sciences, University of Oklahoma (2011) As an ecotoxicologist and ecological physiologist, Dr. Goodchild investigates links between molecular stress responses and fitness-related traits using interdisciplinary approaches spanning cellular physiology, bioenergetics, immunology, and behavior. His work primarily focuses on avian and aquatic systems exposed to contaminants like crude oil, triclosan, and lead, with emphasis on developing biomarkers for ecological hazard assessment. Analysis of his 2015-2020 publications reveals consistent investigation of contaminant effects across taxa, with strong emphasis on avian models (particularly zebra finches) and freshwater mussels. Key themes include biomarker development for oxidative stress, disruption of immune function by petroleum compounds, and behavioral-physiological trade-offs in energy allocation under environmental stress. Dr. Goodchild's scientific awards are not specified in the provided information. He maintains an active undergraduate mentoring program with demonstrable success: Jeff Krall: Accepted into University of Colorado Biochemistry PhD program Taryn Smith: Presented research at Society of Integrative and Comparative Biology conference K. Grisham & L.M. Schmidt: Published as undergraduate co-authors on multiple papers His mentees have transitioned successfully into molecular biology, veterinary medicine, and healthcare graduate programs. While specific grants aren't detailed, his active research program on contaminants suggests ongoing external funding. Dr. Goodchild leads the Ecotoxicology and Wildlife Physiology lab, which employs integrative methodologies to study how environmental stressors impact wildlife physiology and behavior across multiple biological scales.
Kaomei Guan-Schmidt is a Full Professor at the Institute of Pharmacology and Toxicology within the School of Medicine at TU Dresden, where she leads cutting-edge research in cardiovascular regenerative medicine and stem cell biology. Her work primarily focuses on the maturation and functional assessment of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for disease modeling and therapeutic applications. Her research interests include: Cardiovascular Regenerative Medicine Stem Cell Biology Cardiomyocyte Maturation Mechanisms Electrophysiological Characterization Mitochondrial Dynamics in Cardiac Cells Translational Cardiac Disease Modeling Recent publications demonstrate her innovative approaches to enhancing iPSC-CM maturation through integrated strategies involving electrostimulation, metabolic conditioning, and nanoscale engineering. Her work bridges fundamental stem cell biology with clinical cardiology, particularly in biomarker discovery for conditions like atrial fibrillation in stroke patients. Current research trends show strong emphasis on AI-driven analysis of cellular maturity and mitochondrial development in cardiac models. Dr. Guan-Schmidt maintains an active publication record in high-impact journals including Nature Communications and Stem Cells, reflecting her significant contributions to regenerative cardiology. Her collaborative network spans multiple disciplines within TU Dresden's medical and bioengineering research centers. She is affiliated with TU Dresden's Center for Regenerative Therapies Dresden (CRTD) and contributes to interdisciplinary initiatives in the Center for Molecular and Cellular Bioengineering (CMCB), focusing on translating stem cell research into clinical applications for cardiac repair and disease modeling.
